VETO logo

Vetoquinol SA Stock Price

ENXTPA:VETO Community·€927.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author
Create a narrative

VETO Share Price Performance

€78.60
-6.00 (-7.09%)
​
€78.60
-6.00 (-7.09%)
​
Price €78.60

VETO Community Narratives

There are no narratives available yet.

Recent VETO News & Updates

Analyst Estimates: Here's What Brokers Think Of Vetoquinol SA (EPA:VETO) After Its Interim Report

Sep 14
Analyst Estimates: Here's What Brokers Think Of Vetoquinol SA (EPA:VETO) After Its Interim Report

Vetoquinol SA (EPA:VETO) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jul 15
Vetoquinol SA (EPA:VETO) Shares Could Be 43% Below Their Intrinsic Value Estimate

Vetoquinol's (EPA:VETO) Shareholders Will Receive A Bigger Dividend Than Last Year

May 23
Vetoquinol's (EPA:VETO) Shareholders Will Receive A Bigger Dividend Than Last Year

Vetoquinol's (EPA:VETO) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 26
Vetoquinol's (EPA:VETO) Shareholders Will Receive A Bigger Dividend Than Last Year

Vetoquinol SA (EPA:VETO) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Mar 23
Vetoquinol SA (EPA:VETO) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Getting In Cheap On Vetoquinol SA (EPA:VETO) Is Unlikely

Mar 22
Getting In Cheap On Vetoquinol SA (EPA:VETO) Is Unlikely

Vetoquinol SA Key Details

€532.4m

Revenue

€224.2m

Cost of Revenue

€308.2m

Gross Profit

€248.3m

Other Expenses

€60.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
5.08
Gross Margin
57.89%
Net Profit Margin
11.26%
Debt/Equity Ratio
0.5%

Vetoquinol SA Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Solid track record with excellent balance sheet.

0 Risks
3 Rewards
View Full Analysis

About VETO

Founded
1933
Employees
2497
CEO
Matthieu Frechin
WebsiteView website
www.vetoquinol.com

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, pigs, dogs, and cats. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Market Insight

Header cover image

✨Rare Earths: Tiny Market, Outsized Influence

Richard Bowman avatarRichard Bowman
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Last Week
⚡ Utilities: Defensive Dividends Meet the AI Power Surge

⚡ Utilities: Defensive Dividends Meet the AI Power Surge

French Market Performance

  • 7 Days: 3.0%
  • 3 Months: 3.8%
  • 1 Year: 5.4%
  • Year to Date: 7.5%
The market has climbed 3.0% in the last 7 days, lead by the Consumer Discretionary sector with a gain of 5.8%. In contrast, the Energy sector is lagging, dropping 4.9%. In the last year, the market has climbed 5.4%. Earnings are forecast to grow by 12% annually. Market details ›